BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32418732)

  • 1. Chloroquine and hydroxychloroquine during pregnancy: What do we know?
    Lacroix I; Bénévent J; Damase-Michel C
    Therapie; 2020; 75(4):384-385. PubMed ID: 32418732
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold.
    Paumgartten FJR; Delgado IF; Pitta LDR; Oliveira ACAX
    Cad Saude Publica; 2020; 36(5):e00088520. PubMed ID: 32428074
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 4. The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the question.
    Cirino G; Ahluwalia A
    Br J Pharmacol; 2020 Aug; 177(15):3361-3362. PubMed ID: 32602956
    [No Abstract]   [Full Text] [Related]  

  • 5. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor.
    Danjuma MI; Sinha U; Fatima H; Mohamed MFH; Nathoe H
    Eur J Clin Invest; 2020 Nov; 50(11):e13407. PubMed ID: 32918829
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
    Fassihi SC; Nabar NR; Fassihi R
    Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 May; 213():A3-A4. PubMed ID: 32247518
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
    Javelot H; El-Hage W; Meyer G; Becker G; Michel B; Hingray C
    Br J Clin Pharmacol; 2020 Jun; 86(6):1176-1177. PubMed ID: 32350872
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 11. Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
    White CM; Hernandez AV
    J Clin Pharmacol; 2020 Aug; 60(8):949-953. PubMed ID: 32530493
    [No Abstract]   [Full Text] [Related]  

  • 12. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
    Islam M
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
    Roustit M; Guilhaumou R; Molimard M; Drici MD; Laporte S; Montastruc JL;
    Therapie; 2020; 75(4):363-370. PubMed ID: 32473812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function.
    Moura-Neto JA; Misael AM; Silva DRD; D'Avila R; Andreoli MCC; Kraychete A; Bastos K; Nascimento MMD
    J Bras Nefrol; 2020 Aug; 42(2 suppl 1):49-50. PubMed ID: 32877501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
    Piszczatoski CR; Powell J
    Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
    Mvumbi DM
    Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentration-dependent mortality of chloroquine in overdose.
    Watson JA; Tarning J; Hoglund RM; Baud FJ; Megarbane B; Clemessy JL; White NJ
    Elife; 2020 Jul; 9():. PubMed ID: 32639233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.